Cytoreductive surgery (CRS) combined with hyperthermic ... One study identified that colorectal cancer-related peritoneal metastases represent a distinct molecular subtype, known as Consensus ...

To provide updated guidance regarding neoadjuvant chemotherapy (NACT) and primary cytoreductive surgery (PCS) among patients with stage III-IV epithelial ovarian, fallopian tube, or primary peritoneal ...

Heat can kill cancer cells and may make chemotherapy more effective. It is most often used shortly after cytoreductive surgery has been completed for advanced peritoneal cancer. Immunotherapy may ...

The guideline authors used data from 61 studies to provide recommendations on the use of neoadjuvant chemotherapy in patients with newly diagnosed, stage III-IV epithelial ovarian, fallopian tube, or ...

The following is a summary of “Survival outcomes of primary vs interval cytoreductive surgery for International Federation of Gynecology and Obstetrics stage IV ovarian cancer: a nationwide population ...

More information: EeeLN Buckarma et al, Cytoreduction and Hyperthermic Intraperitoneal Paclitaxel and Cisplatin for Gastric Cancer with Peritoneal Metastasis, Annals of Surgical Oncology (2023 ...

The benefits of HIPEC include improved local control of cancer, reduced recurrence rates, and enhanced survival outcomes for ...

AI models outperform traditional statistics in predicting post-complete cytoreduction outcomes in ovarian cancer patients ... methods in predicting CC surgery outcomes for patients with OC.